newsfilter
← Latest News
ACCESS Newswire·

Helix Biopharma Corp. Announces Fiscal 2022 First Quarter Results

RICHMOND HILL, ON / ACCESSWIRE / December 15, 2021 / Helix BioPharma Corp. (TSX:HBP), (" Helix " or the " Company "), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology based on its proprietary technolo